Cowen Remains Bullish on Galapagos NV (GLPG) After AbbVie (ABBV) Declined to Opt-In for Phase III Development of Filgotinib

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/5/2026

1. KRG
2. SPY
3. ALAR
4. SKA-B
5. PBA
6. CCH:LN
7. META
8. CCHGY
9. PRY:IM
10. PRYMY

Go back to Cowen Remains Bullish on Galapagos NV (GLPG) After AbbVie (ABBV) Declined to Opt-In for Phase III Development of Filgotinib
AbbVie (NYSE: ABBV) Delayed: 261.07 +10.01 (3.99%)
Previous Close $251.06    52 Week High $68.12 
Open $252.30    52 Week Low $50.71 
Day High $261.64    P/E 56.63 
Day Low $250.51    EPS $4.61 
Volume 7,114,423       

(NASDAQ: GLPG) Delayed: 27.73 --0 (-0%)
Previous Close $27.73    52 Week High $73.37 
Open $27.73    52 Week Low $37.03 
Day High $27.73    P/E N/A 
Day Low $27.73    EPS $0.00 
Volume 148,676